Form 4: Arteris Inc. Director Sells Shares Under 10b5-1 Trading Plan
SEC Form 4
Arteris Inc. director Saiyed Atiq Raza sold a total of 68,249 shares of common stock in two transactions under a pre-arranged 10b5-1 trading plan.
Summary
- Saiyed Atiq Raza, a director at Arteris Inc., sold 62,186 shares of common stock on December 13, 2024, at a weighted average price of $10.3073 per share.
- These shares were sold in multiple transactions with prices ranging from $10.00 to $10.60.
- A further 6,063 shares were sold on December 16, 2024, at a weighted average price of $10.1232 per share.
- These shares were sold in multiple transactions with prices ranging from $10.00 to $10.28.
- The sales were executed under a 10b5-1 trading plan adopted on June 6, 2024.
- Following these transactions, Mr. Raza indirectly beneficially owns 758,643 shares through the Saiyed Atiq Raza and Nandini Saraiya 2012 Revocable Trust.
Sentiment
Score: 5
Explanation: The document reflects a routine insider transaction under a pre-arranged plan, which is neither particularly positive nor negative. The sentiment is neutral.
Risks
- Sales by insiders can sometimes be perceived negatively by the market, potentially impacting the stock price.
Industry Context
Insider trading activity is a common occurrence in public companies, and these transactions are often scrutinized by investors for insights into management's view of the company's prospects. The use of a 10b5-1 plan indicates that the sales were pre-planned and not based on any recent material non-public information.
Comparison to Industry Standards
- The use of 10b5-1 trading plans is a standard practice for corporate insiders to avoid accusations of trading on non-public information.
- The reported sales are within the typical range of insider transactions for a company of Arteris' size and market capitalization.
- Comparable companies often see similar filings from their directors and officers.
Stakeholder Impact
- The sales may have a minor impact on shareholder sentiment, but the pre-planned nature of the transactions should mitigate any significant negative reaction.
Key Dates
| Date | Description |
|---|---|
| 2024-06-06 | Date the 10b5-1 trading plan was adopted by the Reporting Person. |
| 2024-12-13 | Date of the first reported sale of 62,186 shares. |
| 2024-12-16 | Date of the second reported sale of 6,063 shares. |
| 2024-12-17 | Date the Form 4 was signed. |
Keywords
insider trading, Form 4, stock sale, 10b5-1 plan, Arteris Inc., Saiyed Atiq Raza, share transaction
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.